Skip to content

Insider · CIK 0001877368

Scott B. Willoughby

officer

Files at SGMOQ (SANGAMO THERAPEUTICS, INC). First filing -, latest -.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 24, 2025SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-2,035$0.42$848702,086Nov 26, 2025
Oct 22, 2025SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-44,122$0.66$29k704,121Oct 24, 2025
Aug 24, 2025SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-1,434$0.59$841748,243Aug 26, 2025
Jul 22, 2025SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-31,866$0.48$15k749,677Jul 24, 2025
May 24, 2025SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-1,433$0.47$678781,543May 28, 2025
Apr 22, 2025SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-31,866$0.78$25k782,976Apr 24, 2025
Nov 24, 2024SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-1,430$1.88$2,688828,571Nov 26, 2024
Nov 25, 2024SGMOQ
SANGAMO THERAPEUTICS, INC
FTax withholding
Common Stock
-1,371$1.94$2,660827,200Nov 26, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Scott B. Willoughby: insider trades and track record | InsiderTell